LOXO-292 CAS: 2222755-14-6
| Product Parameters | |
|---|---|
| Catalog No. | BK1U77 |
| CAS.RN | 2222755-14-6 |
| Molecular Formula | C29H34N8O3 |
| Molecular Weight | 542.63 g/mol |
| Purity | NLT 98% |
Product Overview
LOXO-292 is a highly selective and efficient BRAF V600E mutation inhibitor, widely used in drug development and production for targeted cancer therapy. As a pharmaceutical intermediate, this product is mainly used in the synthesis of related anti-tumor drugs and is suitable for small-scale preparation, pilot-scale amplification, and commercial production during the research and development stage. Its stable structure and controllable purity meet the needs of process development at different scales, making it one of the important compounds in the field of precision medicine.
Applications
- Tumor-targeted drug synthesis
- BRAF V600E mutation-related drug development
- Anti-tumor drug process optimization
- Customized synthesis of pharmaceutical intermediates
- Preclinical research and formulation development
Quality & Supply Capability
English Name: LOXO-292 Properties: White to off-white solid with a stable molecular structure and good chemical compatibility, suitable for various organic synthesis routes. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the specific COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from laboratory sample supply to small-scale preparation, pilot-scale amplification, and customized batch production. We can flexibly adjust the supply plan according to the customer's specific requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documentation. Simultaneously, we have a professional technical support team to provide customers with comprehensive technical support from laboratory R&D to industrial production, helping customers efficiently advance process development, route optimization, and project transformation.
Why Choose Bioncan
Focused on pharmaceutical intermediates, with extensive experience in BRAF inhibitor synthesis. Full-scale supply capability, covering all stages from laboratory to commercial production. Provides complete quality control documentation to ensure controllable and traceable product quality. Supports customized solutions to meet the specific specifications and standards of different clients. Comprehensive process optimization and technical support services to facilitate smooth project progress.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 2222755-14-6, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.